Class I Recall of HeartWare Ventricular Assist Device Pumps by HeartWare Inc.

PUBLISHED: Oct 25, 2016

HeartWare Inc. is recalling the HeartWare Ventricular Assist Device (HVAD) pumps due to a design problem with the driveline connector. The driveline is a tube that connects the HVAD's pump to the external controller and power source. Contamination of the driveline may result in fluid or other material entering the pump and causing electrical issues or pump stops that may lead to serious adverse health consequences, including death.

The HVAD helps deliver blood from the heart to the rest of the body. It is used in patients who are at risk of death from end-stage left ventricular heart failure and who are waiting for a heart transplant. The system includes a pump implanted in the space around the pericardium and a controller that controls the speed and function of the pump. The HVAD is designed for use both in and out of hospital settings, including during patient transport. This recall affects all HVADs with serial numbers lower than HW25838, Product Codes 1103 and 1104, manufacturing dates: March 17, 2006 to June 27, 2016. 105 units have been recalled in the U.S.

On August 17, 2016, HeartWare Inc. sent an "Urgent Medical Device Recall Letter" to affected customers. The letter instructed consumers to:

  • Identify affected HVADs in hospital inventory
  • Complete and return the "Acknowledgement Form" attached to the letter
  • Return affected products to HeartWare Inc.
  • After returning the affected products, complete and return the "Completion Form" to a HeartWare representative no later than 2 months from the date on the letter
  • Remind patients about the safe use of the HVAD System, particularly with regard to moisture and proper connection to power and data sources.

Health care providers who have questions should contact their HeartWare representative or contact HeartWare Inc. at cs@heartware.com or 1-877-367-4823 with any questions related to this recall.

Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

Read the MedWatch Safety Alert, including links to the Recall Notice, at the link below.

Want to read the full alert and receive alert emails?

Browse Additional Alerts